Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03744390
Title IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Groupe Francophone des Myelodysplasies
Indications

myelodysplastic syndrome

Therapies

Enasidenib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST